PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Yesterday, in the presence of numerous guests, the new project partners NEMERA and NOVO NORDISK laid the foundation stone for a new manufacturing Hall

The new building will be mostly dedicated to the production of components for Novo Nordisk’s pen needles.

Marc  HÄMEL,  NEMERA’s  CEO  and  Morten  Keller  CASPERSEN,  NOVO NORDISK’s Corporate Vice Président, laid the foundation stone for the new “Hall 6 manufacturing” building of Nemera La Verpillière yesterday, Thursday 21 mars 2019 at Nemera’s Headquarters and production plant in La Verpillière (France). The ceremony was held in the presence of Patrick MARGIER, La Verpillière Mayor and Vice-President of CAPI (Economic regional pole), Yannick NEUDER, Vice- Président of Auvergne Rhône Alpes region, Jean Pierre GIRARD, first Vice- Président of Nord Isère Chamber of Commerce, Aurélie VERNAY, Damien MICHALET, Counsellors of Isère Department Canton and several other local elected officials and stakeholders.

The construction project for this new production hall is the result of a new collaboration  between  NEMERA  and  NOVO  NORDISK,  a  Danish  health company, the world leader in diabetes care, which has also been operating in France for 60 years.

Marc Haëmel, Nemera’s CEO, is very proud of this achievement: “We are very proud of this new collaboration with Novo Nordisk. We share the same values and the same goal, to improve patients’ lives, providing easy and safe drug delivery devices. We leverage decades of manufacturing and development experience in the parenteral device segment and I hope that this first stone is only the beginning of a long way together”

This new building will be almost entirely dedicated to the production of injected plastic parts, for the Novo Nordisk site in Hjørring, Denmark, which is specialized in the production of needles for insulin injection.

Speaking on the occasion, Morten Keller CASPERSEN, Corporate Vice-Président Novo Nordisk said: “We chose Nemera for many good reasons: impressive manufacturing skills, R&D skills and experience in products development and manufacturing. In general, we got the impression that Nemera thinks and acts like us – being open and honest, transparent in what you do, and operating straight forward processes with out too much complexity.

Even though the project is still in the early stages, Nemera has already shown its execution capabilities: the first batches were received with approx. 6 months lead time! So, it is very good start for what I expect will become a long and fruitful collaboration between our two companies, and I am happy to take part in this very concrete manifestation of our agreement that this ceremony represents.”

This investment of 19.3 million euros will create 150 indirect and 50 direct jobs in the La Verpillière site, including operators, logisticians as well as production, maintenance and quality technicians.

This project is funded by Nemera and Novo Nordisk. The building will meet environmental standards.

The event taking place on the first day of spring, a maple was also planted, to symbolize the commitment of both companies in sustainable development.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026